Eli Lilly and Company (LLY) Stock Chart & Stock Price History $865.94 +28.37 (+3.39%) Closing price 03:59 PM EasternExtended Trading$864.16 -1.78 (-0.21%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Eli Lilly and Company Stock Price Performance 5 Day Performance+3.42%1 Month Performance-1.80%3 Month Performance+8.83%6 Month Performance-6.37%Year-To-Date Performance+12.17%1 Year Performance+12.37% Receive LLY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eli Lilly and Company and its competitors with MarketBeat's FREE daily newsletter. Email Address LLY Stock Chart for Monday, March, 24, 2025 LLY Chart by TradingViewRemove Ads Eli Lilly and Company Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/24/2025$839.44$865.94+3.16%$866.87$837.763.10 million shs$821.06 billion03/21/2025$843.35$839.44-0.46%$850.43$825.325.96 million shs$795.93 billion03/20/2025$837.34$843.35+0.72%$854.39$832.464.40 million shs$799.64 billion03/19/2025$821.67$837.34+1.91%$842.13$819.503.79 million shs$793.94 billion03/18/2025$825.48$821.67-0.46%$836.29$812.622.35 million shs$779.08 billion03/17/2025$813.55$825.48+1.47%$829.00$814.572.55 million shs$782.70 billion03/14/2025$798.39$813.55+1.90%$815.21$800.003.10 million shs$771.38 billion03/13/2025$822.26$798.39-2.90%$821.11$795.383.56 million shs$757.01 billion03/12/2025$823.95$822.26-0.21%$834.65$813.263.01 million shs$779.64 billion03/11/2025$828.80$823.95-0.58%$832.35$811.643.77 million shs$781.25 billion Get the Latest News and Ratings for LLY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors with MarketBeat's FREE daily newsletter. 03/10/2025$868.59$828.80-4.58%$863.19$825.785.96 million shs$785.84 billion03/07/2025$912.73$868.59-4.84%$908.00$861.394.82 million shs$823.57 billion03/06/2025$930.12$912.73-1.87%$931.38$898.283.27 million shs$865.43 billion03/05/2025$910.92$930.12+2.11%$930.49$901.643.11 million shs$881.91 billion03/04/2025$930.22$910.92-2.08%$929.16$902.793.34 million shs$863.70 billion03/03/2025$920.44$930.22+1.06%$935.63$910.003.98 million shs$882.01 billion02/28/2025$904.76$920.44+1.73%$921.22$892.614.07 million shs$872.73 billion02/27/2025$915.47$904.76-1.17%$925.50$904.063.14 million shs$857.87 billion02/26/2025$902.47$915.47+1.44%$922.43$896.603.03 million shs$868.02 billion02/25/2025$881.83$902.47+2.34%$912.00$890.745.11 million shs$855.69 billion02/24/2025$874.12$881.83+0.88%$893.11$870.023.01 million shs$836.12 billion Related Companies Johnson & Johnson Stock Chart AbbVie Stock Chart Merck & Co., Inc. Stock Chart Pfizer Stock Chart Bristol-Myers Squibb Stock Chart Zoetis Stock Chart Royalty Pharma Stock Chart Jazz Pharmaceuticals Stock Chart Corcept Therapeutics Stock Chart Perrigo Stock Chart Receive LLY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eli Lilly and Company and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:LLY) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersThis could put Trump on new $100 billAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
